What Happened?
San Diego, CA-based Capstan-Therapeutics Appointed Justin Thacker as Chief Financial Officer
About the Company
Capstan Therapeutics is a biotechnology company dedicated to advancing in vivo cell reprogramming. The core platform technology comprises proprietary targeted lipid nanoparticles conjugated with a recombinant protein binder such as monoclonal antibodies (tLNPs) designed to deliver payloads, including mRNA or gene editing tools, that can reprogram specific cell types in vivo. The platform technology has the potential to generate transformative therapies with applications across a broad range of disease areas, including oncology, autoimmune disorders, fibrosis, and monogenic blood disorders.
About the Person
Justin Thacker is Chief Financial Officer at Capstan Therapeutics. Previously, Justin held various senior HR leadership roles in the industry.
Info Source
News
Short Profile